{"id":68436,"date":"2022-09-24T21:22:59","date_gmt":"2022-09-24T21:22:59","guid":{"rendered":"https:\/\/www.pharmacie-vezere.com\/promotions\/?p=68436"},"modified":"2022-09-25T10:38:33","modified_gmt":"2022-09-25T10:38:33","slug":"ipsen-finalise-lacquisition-depizyme-et-elargit-son-portefeuille-en-oncologie","status":"publish","type":"post","link":"https:\/\/www.pharmacie-vezere.com\/promotions\/ipsen-finalise-lacquisition-depizyme-et-elargit-son-portefeuille-en-oncologie\/","title":{"rendered":"Ipsen finalise l&#8217;acquisition d&#8217;Epizyme et \u00e9largit son portefeuille en oncologie"},"content":{"rendered":"\n<p class=\"has-medium-font-size\">PARIS, FRANCE, 12 ao\u00fbt 2022 -Ipsen a annonc\u00e9 aujourd&#8217;hui la cl\u00f4ture de l&#8217;acquisition d&#8217;Epizyme pour moins de 1,50 $ par action. La soci\u00e9t\u00e9 acquerra \u00e9galement tous les droits \u00e0 la valeur conditionnelle. Dans le cadre de la transaction, Ipsen acquiert Epizyme et son produit phare, Tazverik (tazemetostat), un inhibiteur d&#8217;EZH2 qui a re\u00e7u une approbation acc\u00e9l\u00e9r\u00e9e.Il est actuellement indiqu\u00e9 pour les adultes atteints de lymphome folliculaire (FL) r\u00e9cidivant ou r\u00e9fractaire et dont les g\u00e8nes tumoraux sont positifs pour une mutation EZH2 d\u00e9tect\u00e9e par l&#8217;un des tests approuv\u00e9s par la FDA, qui ont re\u00e7u au moins deux traitements syst\u00e9miques ant\u00e9rieurs. Pour les patients adultes atteints de lymphome folliculaire r\u00e9cidivant ou r\u00e9fractaire qui n&#8217;ont pas d&#8217;autres options th\u00e9rapeutiques satisfaisantes, ainsi que pour les adultes et les enfants \u00e2g\u00e9s de 16 ans et plus atteints de sarcome \u00e9pith\u00e9lio\u00efde m\u00e9tastatique ou localement avanc\u00e9.<\/p>\n\n\n\n<p>Ipsen gagne le premier inhibiteur SETD2 d&#8217;Epizyme, qui a obtenu le statut Fast Track de la FDA en 2021 et est actuellement en cours d&#8217;\u00e9valuation dans un essai de phase I\/Ib avec le my\u00e9lome multiple r\u00e9cidivant ou r\u00e9fractaire et le lymphome diffus \u00e0 grandes cellules B, ainsi qu&#8217;un portefeuille de programmes pr\u00e9cliniques ax\u00e9s sur les cibles \u00e9pig\u00e9n\u00e9tiques.<\/p>\n\n\n\n<figure class=\"wp-block-image alignright size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-content\/uploads\/2022\/09\/\u0437\u0430\u0432\u0430\u043d\u0442\u0430\u0436\u0435\u043d\u043d\u044f-2022-09-24T234739.259.jpg\" alt=\"\" class=\"wp-image-68438\" width=\"217\" height=\"235\" srcset=\"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-content\/uploads\/2022\/09\/\u0437\u0430\u0432\u0430\u043d\u0442\u0430\u0436\u0435\u043d\u043d\u044f-2022-09-24T234739.259.jpg 215w, https:\/\/www.pharmacie-vezere.com\/promotions\/wp-content\/uploads\/2022\/09\/\u0437\u0430\u0432\u0430\u043d\u0442\u0430\u0436\u0435\u043d\u043d\u044f-2022-09-24T234739.259-200x218.jpg 200w\" sizes=\"auto, (max-width: 217px) 100vw, 217px\" \/><\/figure>\n\n\n\n<p>&#8220;Tout au long de la phase de planification pr\u00e9c\u00e9dant la cl\u00f4ture, nous avons continu\u00e9 \u00e0 \u00eatre impressionn\u00e9s par le potentiel de Tazverik, ainsi que par le reste du pipeline. Maintenant que l&#8217;accord est conclu, nous sommes ravis de travailler en \u00e9troite collaboration avec nos coll\u00e8gues d&#8217;Epizyme pour tirer parti de l&#8217;infrastructure \u00e9tablie d&#8217;Ipsen afin que ces m\u00e9dicaments puissent atteindre davantage de patients. En outre, gr\u00e2ce \u00e0 cette transaction, Ipsen acquiert une expertise scientifique et nous sommes impatients d&#8217;int\u00e9grer les deux \u00e9quipes qui partagent l&#8217;objectif de fournir des options de traitement innovantes aux patients mal desservis&#8221;, a d\u00e9clar\u00e9 David Loew, directeur g\u00e9n\u00e9ral d&#8217;Ipsen.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">A propos de Tazverik\u00ae (tazemetostat)<\/h2>\n\n\n\n<p>Tazverik est un inhibiteur de la m\u00e9thyltransf\u00e9rase indiqu\u00e9 pour le traitement de :<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Adultes et enfants \u00e2g\u00e9s de 16 ans et plus atteints de sarcome \u00e9pith\u00e9lio\u00efde m\u00e9tastatique ou localement avanc\u00e9 non \u00e9ligible \u00e0 une r\u00e9section compl\u00e8te.<\/li><li>Les patients adultes atteints de lymphome folliculaire r\u00e9cidivant\/r\u00e9fractaire dont les tumeurs sont positives pour une mutation EZH2, qui ont re\u00e7u au moins 2 traitements pr\u00e9c\u00e9dents et dont la tumeur est d\u00e9tectable par un test approuv\u00e9 par la FDA.<\/li><li>Pour les adultes atteints d&#8217;un lymphome folliculaire r\u00e9cidivant ou r\u00e9fractaire et ne disposant d&#8217;aucune autre option th\u00e9rapeutique, le l\u00e9nalidomide peut \u00eatre utilis\u00e9. Pour les patients \u00e9ligibles, les \u00e9tudes sur le l\u00e9nalidomide ont montr\u00e9 une am\u00e9lioration des taux de r\u00e9ponse et une tendance \u00e0 l&#8217;am\u00e9lioration des dur\u00e9es de survie.<\/li><\/ul>\n\n\n\n<p>Ces indications sont approuv\u00e9es dans le cadre de la proc\u00e9dure d&#8217;approbation acc\u00e9l\u00e9r\u00e9e. Des \u00e9tudes post-commercialisation seront n\u00e9cessaires afin de confirmer le b\u00e9n\u00e9fice clinique attendu et de conserver les approbations acc\u00e9l\u00e9r\u00e9es d\u00e9sign\u00e9es.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>PARIS, FRANCE, 12 ao\u00fbt 2022 -Ipsen a annonc\u00e9 aujourd&#8217;hui la cl\u00f4ture de l&#8217;acquisition d&#8217;Epizyme pour moins de 1,50 $ par action. La soci\u00e9t\u00e9 acquerra \u00e9galement tous les droits \u00e0 la valeur conditionnelle. Dans le cadre de la transaction, Ipsen acquiert Epizyme et son produit phare, Tazverik (tazemetostat), un inhibiteur d&#8217;EZH2 qui a re\u00e7u une approbation [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":68438,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[684],"tags":[],"class_list":["post-68436","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nouvelles-pharmaceutiques"],"_links":{"self":[{"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/posts\/68436","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/comments?post=68436"}],"version-history":[{"count":2,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/posts\/68436\/revisions"}],"predecessor-version":[{"id":68439,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/posts\/68436\/revisions\/68439"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/media\/68438"}],"wp:attachment":[{"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/media?parent=68436"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/categories?post=68436"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/tags?post=68436"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}